China Meheco Group Co., Ltd. (SHA:600056)

China flag China · Delayed Price · Currency is CNY
10.49
+0.11 (1.06%)
At close: Mar 6, 2026
-0.29%
Market Cap 15.69B
Revenue (ttm) 33.23B
Net Income (ttm) 513.36M
Shares Out 1.50B
EPS (ttm) 0.34
PE Ratio 30.57
Forward PE n/a
Dividend 0.11 (1.00%)
Ex-Dividend Date Sep 26, 2025
Volume 9,925,280
Average Volume 13,045,207
Open 10.34
Previous Close 10.38
Day's Range 10.31 - 10.50
52-Week Range 9.54 - 12.48
Beta 0.20
RSI 43.68
Earnings Date Apr 25, 2026

About China Meheco Group

China Meheco Group Co., Ltd. engages in the manufacture, marketing, and trade of pharmaceuticals and medical devices in China and internationally. The company is involved in the planting and sale of Chinese medicinal materials, as well as the provision of related technical and warehousing services. Its drug products cover therapeutic fields, such as anti-infection, cardiovascular, hormones and endocrine regulation, respiratory and digestive systems, nutritional supplements, antipyretic analgesics, and other therapeutic areas as well as Chinese ... [Read more]

Sector Healthcare
Founded 1983
Employees 8,368
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600056
Full Company Profile

Financial Performance

In 2024, China Meheco Group's revenue was 34.15 billion, a decrease of -12.04% compared to the previous year's 38.82 billion. Earnings were 535.47 million, a decrease of -48.91%.

Financial Statements

News

There is no news available yet.